Formulations | Ratios of chitosan to HAp | Cross-linking agent Calcium chloride (g) | Atorvastatin (mg) | |
---|---|---|---|---|
Chitosan (2%) | Hydroxyapatite | |||
Composite bioscaffolds | ||||
Hac1 | 1 | 1 | - | - |
Hac2 | 1 | 2 | - | - |
Hac3 | 1 | 3 | - | - |
Hac4 | 1 | 4 | - | - |
Hac5 | 1 | 5 | - | - |
Cross-linked composite bioscaffolds | ||||
Hbc1 | 1:1 | 0.5 | - | |
Hbc2 | 1:1 | 1 | - | |
Hbc3 | 1:1 | 1.5 | - | |
Atorvastatin-loaded composite bioscaffolds | ||||
Hcc1 | 1:1 | 1.5 | 250 | |
Hcc2 | 1:1 | 1.5 | 500 | |
Hcc3 | 1:1 | 1.5 | 750 |